SMARCA4 and inflammatory breast carcinoma: Genes involved in chromatin remodeling were also more frequently altered in IBC, such as EZH2 and SMARCA4, altered in 5% of IBC, providing a rationale for the evaluation of epigenetic modifiers for the treatment of IBC.